Become a member
LyonbioLink
Job offers
Fr
En
Lyonbiopole
Lyonbiopole missions
The Lyonbiopole team
Governance
Board of Directors
Members of the Board
The technical group, Gtech
Our public funders
Our members and associated members
Press area
Press releases
Communication tools
Mobile app
Become a member
Contact us
Research and innovation
Goals
R&D project support
Setting up and funding a project
Project accreditation
Supporting a European project
Project monitoring
Scientific coordination
Partnering Day
The Microbiota and Health Day
Workshops and topicaldays
Project funding
Lyonbiopole actions
Calls for projects
Clinical innovation
Structuring program
MabDesign
Upcoming events
Economic development
Goals
Private investment
Private Inv€stments Day
Inv€stor Meetings
Access to skills
GPEC and training initiatives
Intellectual property and consortium agreements
Networking
Lunch Break Partnering
Open Innovation Meetings
Life science directory
Upcoming events
International
Goals
Europe
The support offer to Europe
Main European funding
Our clusters partners
Our European projects
International funding tools
The International Representation and Expertise Programme – IREP
ITPP
Cooperation with the CQDM
Our international trade missions
Upcominig events
Facilities
Our labs offer
Our offices offer
Contact-us
Directories
Companies
Consultants & Service providers
Research units
Healthcare institutions
Collaborative Clinical Research Structures
R&D projects
Diary – News
Upcoming events
All events
Our events
In partnership
Around our themes
News
All news
Lyonbiopole
Our members
Focus on
New members
Blog
Newsletter
Lyonbiopole in action
Lyonbiopole
Governance
Headlines
Osivax Announces Promising Phase 2a Results with Universal Influenza Vaccine Candidate OVX836
January
3
th
,
2022
MICROLIGHT3D MARKS FIFTH ANNIVERSARY AND REINFORCES TEAM
Décember
3
th
,
2021
Poxel annonce la création d’un Conseil Scientifique dédié aux maladies métaboliques rares
Décember
6
th
,
2021
All news
Lyonbiopole Governance 
